• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Study links gene to Alzheimer’s and Down syndrome

Study links gene to Alzheimer’s and Down syndrome

January 14, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Study links gene to Alzheimer’s and Down syndrome. Researchers at the University of British Columbia and the Vancouver Coastal Health Research Institute identified the gene that destroys brain cells, or neurons, in individuals with Alzheimer’s disease and Down syndrome, reports The Vancouver Sun.

Report: Alzheimer’s burden to increase as population ages. A new report from a Minnesota legislature working group says the state must prepare now for the significant costs and medical demands associated with Alzheimer’s disease as baby boomers retire. The group issued seven recommendations designed to help the state get ready for the expected spike in Alzheimer’s patients according to Minnesota Public Radio.

Study casts doubt over breastfeeding. Feeding babies only breast milk in their first six months might not be best for their development, scientists from University College London warned, reports the BBC.

Healthcare repeal vote: Wednesday. Debate on the Republicans’ healthcare reform repeal legislation will begin again Tuesday with a vote in the House of Representatives expected to occur the next day. This is a largely symbolic vote meant more to signal GOP efforts to undermine the current US healthcare reform by under-funding it.

But in the wake of the Arizona shootings, there’s urging for a new approach to changing last year’s US healthcare reform bill.

So what if, after they go through the obligatory repeal and stop-the-repeal exercise, our elected leaders would begin negotiating a health care detente.

Because no one has any intention of going back to square one on health care, they would have to use the Affordable Care Act as the vehicle. That would be painful for politicians who campaigned on the erroneous premise that the law is, as newly elected U.S. Rep. Vicky Hartzler from Missouri put it in a tweet last week, a ’job-killing, deficit-increasing, unconstitutional government takeover.’

But what if they actually tried?

Fighting generic drugs. A lesser-known fight against healthcare reform legislation is the headway brand-name drug makers are making against rules favoring generic biologics.

Hidden pharma donations. Pharmaceutical companies have donated eight-figure amounts to health advocacy groups but few of these organizations acknowledged the drug-company donations. Only one in four organizations acknowledged the report and the authors say drug companies should be required to make these contributions public.

Acetadote FDA approval. The acetaminophen poisoning treatment from Cumberland Pharmaceuticals has received approval by the U.S. Food and Drug Administration. The new drug is a preservative-free version.

Making the case for medical innovation. From Thursday’s Council for American Medical Innovation summit: “”When you think about it, medical innovation can best be characterized as a human and economic value proposition that our nation simply cannot turn down. In short, value for our economy, for our competitiveness, for our ability to create jobs, and above all, for our long-term health and wellness.”

Dealflow and more. Dendreon will raise $500 million through debt; Endo Pharmaceuticals will use $500 million for acquisitions “seeking health information technology and diagnostic tools for cancer and urology;” Javelin Venture Partners raised $11.7 million for a new fund; Cell Therapeutics raised $25 million.

Material from MedCity News was used in this report.

Filed Under: Business/Financial News, Genomics/Molecular Diagnostics, Neurological, News Well Tagged With: Alzheimer's disease

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy